A Study of Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH)
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the dietary supplement Siliphos, which comes from
milk thistle, to determine whether it is safe and well-tolerated in adults who have
non-alcoholic steatohepatitis (NASH). An additional aim of this study is to determine whether
Siliphos may be beneficial in treatment of NASH as indicated by improvement in liver enzymes
(ALT and AST). The study hypothesis is that Siliphos will be safe and well-tolerated in
people with NASH and will result in a decrease in the liver enzymes ALT and AST.
Phase:
Phase 2
Details
Lead Sponsor:
Heather Patton University of California, San Diego